v3.26.1
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   24,681,000      
Beginning balance at Dec. 31, 2024 $ 52,478 $ 2 $ 385,114 $ 16 $ (332,654)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 1,680   1,680    
Issuance of common stock upon exercise of warrants (in shares)   426,000      
Issuance of common stock upon exercise of stock options (in shares)   22,000      
Issuance of common stock upon exercise of stock options 21   21    
Issuance of common stock in conjunction with vesting of restricted stock units (in shares)   63,000      
Private placement, net of transaction costs (in shares)   21,592,000      
Private placement, net of transaction costs 94,548 $ 2 94,546    
Unrealized loss on investments, net of tax (15)     (15)  
Net Income (Loss) 73,016       73,016
Ending balance (in shares) at Mar. 31, 2025   46,784,000      
Ending balance at Mar. 31, 2025 $ 221,728 $ 4 481,361 1 (259,638)
Beginning balance (in shares) at Dec. 31, 2025 47,145,719 47,145,000      
Beginning balance at Dec. 31, 2025 $ 136,311 $ 4 489,437 120 (353,250)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense $ 2,193   2,193    
Issuance of common stock upon exercise of stock options (in shares) 0        
Issuance of common stock in conjunction with vesting of restricted stock units (in shares)   51,000      
Unrealized loss on investments, net of tax $ (135)     (135)  
Net Income (Loss) $ (22,194)       (22,194)
Ending balance (in shares) at Mar. 31, 2026 47,196,564 47,196,000      
Ending balance at Mar. 31, 2026 $ 116,175 $ 4 $ 491,630 $ 15 $ (375,444)